Kathy Gunn

Kathy Gunn serves as the Senior Director of Clinical Operations. She has over 15-years of documented success in both B2B and B2C experience within the Pharmaceutical (Rx & OTC) and Medical Device (DME & MSE) markets. Roles throughout her career include: Sales, Training, Product Management, Key Accounts and Marketing Management. Prior to her current role, Kathy was a Director with a division of the Ferndale Pharma Group.

Kathy serves as a Board Member for Angels of Hope, a Michigan-based nonprofit that provides financial assistance to families as they battle cancer. She received her B.Sc. degree in Biomedical Sciences and Chemistry from Western Michigan University and holds an M.B.A. from the DeVos Graduate School at Northwood University. Kathy is an alumna of Alpha Chi Omega.